CDI In the News
Cambridge, Mass., and Madison, Wis. [May 17, 2021] – BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, FUJIFILM Cellular Dynamics, Inc. a leading global developer and manufacturer of human induced pluripotent stem (iPS) cell technologies, and Opsis Therapeutics, LLC, a joint venture of FUJIFILM Cellular Dynamics (FCDI) and David Gamm, M.D.,….
FUJIFILM Cellular Dynamics, Inc. and Sana Biotechnology, Inc. announced today that Sana has been granted a non-exclusive right to use FUJIFILM Cellular Dynamics’ iPSC platform for the development of commercial cell therapies.
Cell & Gene Therapy Insights 2020; 6(10), 1507–1512
Wisconsin State Journal